plumbagin has been researched along with Invasiveness, Neoplasm in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Im, E; Kang, CG; Lee, EO; Lee, HJ | 1 |
| Chen, W; Huang, D; Huo, L; Li, J; Lin, Y; Wei, J; Wei, Y; Zhao, C; Zhong, J | 1 |
| Ketchart, W; Mutirangura, A; Pradubyat, N; Sakunrangsit, N | 1 |
| Alem, FZ; Bejaoui, M; Isoda, H; Rhourri-Frih, B; Villareal, MO | 1 |
| Chen, G; Qin, J; Ren, Q; Xiao, B; Xiao, X; Yue, Y | 1 |
| Chen, Y; Li, J; Liu, X; Ma, J; Wei, Y; Yang, Q; Zhang, Y; Zhao, C; Zhao, T; Zhong, J | 1 |
| Aziz, MH; Dreckschmidt, NE; Verma, AK | 1 |
| Ahn, KS; Bist, P; Hay, HS; Kannaiyan, R; Kapoor, S; Koay, ES; Kumar, AP; Li, F; Lim, LH; Manu, KA; Rajendran, P; Ramachandran, L; Ramesh, B; Sethi, G; Shanmugam, MK; Swamy, SN; Vali, S | 1 |
| Cai, X; Guo, W; Li, W; Li, Z; Lin, Z; Liu, M; Luo, J; Wu, X; Xiao, J; Xie, J; Xu, L; Yang, Z | 1 |
9 other study(ies) available for plumbagin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Movement; Humans; Lung; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplasm Invasiveness; Osteopontin; Plumbaginaceae; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction | 2017 |
Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Stromal Cell-Derived Factor (SDF-1)/CXCR4-CXCR7 Axis.
Topics: Angiogenesis Inhibitors; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; Liver; Liver Neoplasms; Naphthoquinones; Neoplasm Invasiveness; Neovascularization, Pathologic; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; Stromal Cells; Vascular Endothelial Growth Factor A | 2019 |
NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Neoplasm Invasiveness; Tamoxifen | 2020 |
Elucidation of the effect of plumbagin on the metastatic potential of B16F10 murine melanoma cells via MAPK signalling pathway.
Topics: Animals; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Melanoma; Melanoma, Experimental; Mice; Naphthoquinones; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Plant Extracts; Signal Transduction; Wound Healing | 2020 |
Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway in vitro.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Naphthoquinones; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |
Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplasm Invasiveness; Neovascularization, Pathologic; Signal Transduction; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.
Topics: Animals; Apoptosis; Base Sequence; Cell Division; DNA Primers; Electrophoretic Mobility Shift Assay; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Naphthoquinones; Neoplasm Invasiveness; Plants, Medicinal; Prostatic Neoplasms | 2008 |
Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Computer Simulation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Luciferases; Models, Biological; Naphthoquinones; Neoplasm Invasiveness; NF-kappa B; Protein Binding; Receptors, CXCR4; Stomach Neoplasms; Transcription, Genetic | 2011 |
Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Topics: Actins; Animals; Antigens, Differentiation; Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cytokines; Enzyme Activation; Female; Gene Expression; Humans; Inhibitory Concentration 50; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Naphthoquinones; Neoplasm Invasiveness; NF-kappa B; Osteoclasts; Osteolysis; Protein Binding; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; TNF Receptor-Associated Factor 6; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2012 |